Number of Shares
229.00
Current Holdings Value*
$240,690.00
% of Portfolio
1.67%
Total Estimate Gain
$37,692.67
% of Total Estimate Gain
8.97%

AXS Alternative Value Fund's Regeneron Pharmaceuticals Inc Holding Summary

As of 2024-06-30, Investment Managers Series Trust II held 229.00 shares of Regeneron Pharmaceuticals Inc(REGN), totaling $240,690.00. This investment constitutes 1.67% of their stock portfolio, and Investment Managers Series Trust II now holds 0% of the outstanding Regeneron Pharmaceuticals Inc(REGN) stock.

The initial trade took place in 2021Q1. And since then AXS Alternative Value Fund has made 6 purchases of REGN, at an average price of $638.58, for a total of 658.00 shares. In addition, there have been 5 sales at an average price of $787.07 for 429.00 shares. Based on historical transaction data and REGN's current price of $525.00, AXS Alternative Value Fund's estimated gain on his REGN holdings is $37,692.67, reflecting a 8.97% gain to date.

AXS Alternative Value Fund REGN ($525.00) Holding Chart

AXS Alternative Value Fund REGN ($525.00) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1